Amanta Healthcar

44
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE084K01015
  • NSEID: AMANTA
  • BSEID: 544502
INR
156.39
7.44 (4.99%)
BSENSE

Jun 19, 03:30 PM

BSE+NSE Vol: 1.27 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is -2.01% vs 8.19% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 3.79% vs 9.01% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -16.92% vs -4.63% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 189.02% vs 272.14% in Mar 2024

Compare Profit and Loss Results of Amanta Healthcar
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
274.00
370.00
-96.00
-25.95%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
274.00
370.00
-96.00
-25.95%
Expenditure (Ex Depriciation)
Stock Adjustments
-19.00
-6.00
-13.00
-216.67%
Raw Materials Consumed
113.00
170.00
-57.00
-33.53%
Power & Fuel Cost
22.00
18.00
4.00
22.22%
Employee Cost
36.00
60.00
-24.00
-40.00%
Operating Expenses
23.00
38.00
-15.00
-39.47%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
24.00
24.00
0.00
0.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
4.00
5.00
-1.00
-20.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
215.00
340.00
-125.00
-36.76%
Operating Profit (PBDIT) excl Other Income
59.00
29.00
30.00
103.45%
Other Income
1.00
11.00
-10.00
-90.91%
Operating Profit (PBDIT)
61.00
40.00
21.00
52.50%
Interest
27.00
13.00
14.00
107.69%
Profit before Depriciation and Tax
33.00
27.00
6.00
22.22%
Depreciation
18.00
19.00
-1.00
-5.26%
Profit Before Taxation & Exceptional Items
14.00
8.00
6.00
75.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
14.00
8.00
6.00
75.00%
Provision for Tax
4.00
2.00
2.00
100.00%
Profit After Tax
10.00
5.00
5.00
100.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
16.00
163.00
-147.00
-90.18%
Profit Available for appropriations
26.00
169.00
-143.00
-84.62%
Appropriations
26.00
169.00
-143.00
-84.62%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
3.71
1.22
2.49
204.10%
Profit And Loss - Net Sales
Net Sales 274.71 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -2.01% vs 8.19% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 59.67 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 3.79% vs 9.01% in Mar 2024

Profit And Loss - Interest
Interest 27.95 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -16.92% vs -4.63% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 10.50 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 189.02% vs 272.14% in Mar 2024